ClinicalTrials.Veeva

Menu

Patient-Centered NeuroRehabilitation (PCN)

University of Michigan logo

University of Michigan

Status

Enrolling

Conditions

Cognitive Deficit

Treatments

Device: Active tACS
Device: Active tRNS
Device: Sham tACS
Device: Sham tDCS
Behavioral: Cognitively based intervention
Device: Sham tRNS
Device: Active tDCS

Study type

Interventional

Funder types

Other

Identifiers

NCT03036319
HUM00111090

Details and patient eligibility

About

As individuals grow older, a number of factors can reduce our cognitive (or thinking) abilities such as "normal" aging, neurodegenerative diseases, and cardiovascular disease. This study will evaluate whether cognitive rehabilitation and transcranial electrical stimulation (TES) can improve cognitive abilities. Cognitive rehabilitation refers to methods that are used to improve tasks people have trouble doing in everyday life. Transcranial electrical stimulation uses small amounts of electricity to try to alter brain functioning. These approaches may help improve cognitive abilities like attention, learning, memory, finding words, and problem solving as well as everyday functioning. The goal of this study is to identify how to best use these methods, either alone or in combination.

Full description

The primary objective of this study is to evaluate the feasibility of a neurorehabilitation treatment tailored to individual patient needs, with the ultimate goal of maximizing cognitive and real-world functioning for older adults with cognitive aging, mild cognitive impairment (MCI), neurodegenerative, or other neurological diseases/conditions.

Transcranial electrical stimulation (TES) is a non-invasive, neurorehabilitation procedure in which a weak electric current is passed between electrodes that are placed on the scalp with the intention of modulating excitability of the underlying brain regions. Because the field of TES is relatively young, rapidly evolving, and primarily focused on cognitive neuroscience with "healthy" individuals, there is a clear need for well-conceptualized and conducted clinical research. The current protocol is intentionally broad with respect to both methodology and patient characteristics in order to tailor potential TES interventions to individual patients or small samples. The current protocol utilizes various forms of TES including transcranial direct current stimulation (tDCS), alternating current stimulation (tACS), and random noise stimulation (tRNS) and sham stimulation in older adults. As this is a cross-over design, some participants may receive active (or "real") TES and/or sham TES conditions.This includes head to head comparisons of the different forms of TES. Additionally, TES could be performed in conjunction with cognitively-based intervention since this may enhance the neuroplastic response of the targeted brain region(s) while at the same time shaping/optimizing the pathways that are engaged by cognitively-based interventions. This broad approach is important since etiological differences in cognitive impairment may necessitate distinct interventions.

Enrollment

500 estimated patients

Sex

All

Ages

50+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Individuals who have reported cognitive dysfunction and cognitively intact participants.
  2. Participants will be age 50 or older

Exclusion criteria

  1. A history of epilepsy
  2. Sensory or motor impairments that limit the ability to take part in the study
  3. Current alcohol or drug abuse/dependence
  4. Those who are currently pregnant or may become pregnant during the duration of the study (if there is a question of pregnancy, pregnancy tests will be available for participants at no charge)

Those who are being evaluated for TES methodology will also be excluded for 1) metallic or electronic implant 2) skull plates or other cranial implants that affect TES

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

500 participants in 7 patient groups, including a placebo group

Active TES
Experimental group
Description:
Participants will receive "real" tES (tDCS, tACS, tRNS) in which they receive up to 4 milliamps (mA) of stimulation per electrode for up to 40 minutes for up to 260 sessions. As this may be a cross-over design, some participants may receive active and sham conditions.
Treatment:
Device: Active tDCS
Device: Active tRNS
Device: Active tACS
Sham TES
Placebo Comparator group
Description:
Participants undergoing this condition will have the exact same procedures as the active group, with the exception that they will receive only sham stimulation for up to 260 sessions.
Treatment:
Device: Sham tRNS
Device: Sham tDCS
Device: Sham tACS
Cognitively based intervention
Experimental group
Description:
Participants may receive a cognitively based intervention that targets the particular cognitive and/or functional abilities of interest. This includes methods of cognitive training, cognitive remediation, and cognitive rehabilitation.
Treatment:
Behavioral: Cognitively based intervention
Active TES + Cognitively based intervention
Experimental group
Description:
This condition combines active TES and cognitively based interventions for some or all of the study sessions
Treatment:
Device: Active tDCS
Behavioral: Cognitively based intervention
Device: Active tRNS
Device: Active tACS
Sham TES + Cognitively based intervention
Experimental group
Description:
This condition combines sham TES and cognitively based interventions for some or all of the study sessions
Treatment:
Device: Sham tRNS
Behavioral: Cognitively based intervention
Device: Sham tDCS
Device: Sham tACS
Active TES, Sham TES, Cognitively based interventions
Experimental group
Description:
This condition combines active and sham TES with cognitively based interventions using a cross-over design
Treatment:
Device: Active tDCS
Device: Sham tRNS
Behavioral: Cognitively based intervention
Device: Sham tDCS
Device: Sham tACS
Device: Active tRNS
Device: Active tACS
Active and Sham TES
Experimental group
Description:
Participants will receive active and sham TES
Treatment:
Device: Active tDCS
Device: Sham tRNS
Device: Sham tDCS
Device: Sham tACS
Device: Active tRNS
Device: Active tACS

Trial contacts and locations

1

Loading...

Central trial contact

Kayla Rinna, M.S.; Eileen Robinson, RN, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems